| 1 |
Daroudi R, Nahvijou A, Arab M, Faramarzi A, Kalaghchi B, Sari AA, Javan-noughabi J. A cost-effectiveness modeling study of treatment interventions for stage I to III esophageal squamous cell carcinoma. Cost Eff Resour Alloc 2022;20. [DOI: 10.1186/s12962-022-00352-5] [Reference Citation Analysis]
|
| 2 |
Vantanasiri K, Iyer PG. State-of-the-art management of dysplastic Barrett's esophagus. Gastroenterology Report 2022;10. [DOI: 10.1093/gastro/goac068] [Reference Citation Analysis]
|
| 3 |
Han S, Low DE. LAPAROSCOPIC ANTIREFLUX SURGERY: ARE OLD QUESTIONS ANSWERED? SHOULD IT BE USED CONJOINED WITH ENDOSCOPIC THERAPY FOR BARRETT’S ESOPHAGUS? ABCD, arq bras cir dig 2022;35. [DOI: 10.1590/0102-672020210002e1664] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
|
| 4 |
Reddy CA, Tavakkoli A, Chen VL, Korsnes S, Bedi AO, Carrott PW, Chang AC, Lagisetty KH, Kwon RS, Elmunzer BJ, Orringer MB, Piraka C, Prabhu A, Reddy RM, Wamsteker E, Rubenstein JH. Long-Term Quality of Life Following Endoscopic Therapy Compared to Esophagectomy for Neoplastic Barrett's Esophagus. Dig Dis Sci 2021;66:1580-7. [PMID: 32519141 DOI: 10.1007/s10620-020-06377-1] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 5 |
Hu Y, McMurry TL, Goudreau B, Leick KM, Le TM, Zaydfudim VM. Comparative Effectiveness of Lymphadenectomy Strategies During Curative Resection for Gastric Adenocarcinoma. J Gastrointest Surg 2020;24:2212-8. [PMID: 31515762 DOI: 10.1007/s11605-019-04393-9] [Reference Citation Analysis]
|
| 6 |
Kumarasinghe MP, Bourke MJ, Brown I, Draganov PV, McLeod D, Streutker C, Raftopoulos S, Ushiku T, Lauwers GY. Pathological assessment of endoscopic resections of the gastrointestinal tract: a comprehensive clinicopathologic review. Mod Pathol 2020;33:986-1006. [PMID: 31907377 DOI: 10.1038/s41379-019-0443-1] [Cited by in Crossref: 19] [Cited by in F6Publishing: 19] [Article Influence: 6.3] [Reference Citation Analysis]
|
| 7 |
Li J, Jia Y, Cheng Y, Wang J. Chemoradiotherapy vs radiotherapy for nonoperative early stage esophageal cancer: A seer data analysis. Cancer Med 2020;9:5025-34. [PMID: 32441890 DOI: 10.1002/cam4.3132] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.7] [Reference Citation Analysis]
|
| 8 |
Raphael KL, Trindade AJ. Management of Barrett’s esophagus with dysplasia refractory to radiofrequency ablation. World J Gastroenterol 2020; 26(17): 2030-2039 [PMID: 32536772 DOI: 10.3748/wjg.v26.i17.2030] [Cited by in CrossRef: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.7] [Reference Citation Analysis]
|
| 9 |
Semenkovich TR, Hudson JL, Subramanian M, Mullady DK, Meyers BF, Puri V, Kozower BD. Trends in Treatment of T1N0 Esophageal Cancer. Ann Surg 2019;270:434-43. [PMID: 31274653 DOI: 10.1097/SLA.0000000000003466] [Cited by in Crossref: 21] [Cited by in F6Publishing: 25] [Article Influence: 7.0] [Reference Citation Analysis]
|
| 10 |
Puri V, Meyers BF. Decision Analytic Techniques and Other Decision Processes. Difficult Decisions in Surgery: An Evidence-Based Approach 2020. [DOI: 10.1007/978-3-030-47404-1_3] [Reference Citation Analysis]
|
| 11 |
Singh T, Sanghi V, Thota PN. Current management of Barrett esophagus and esophageal adenocarcinoma. Cleve Clin J Med 2019;86:724-32. [PMID: 31710585 DOI: 10.3949/ccjm.86a.18106] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 12 |
Patel A, Gyawali CP. Screening for Barrett's Esophagus: Balancing Clinical Value and Cost-effectiveness. J Neurogastroenterol Motil 2019;25:181-8. [PMID: 30827080 DOI: 10.5056/jnm18156] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 1.8] [Reference Citation Analysis]
|
| 13 |
Honing J, Kievit W, Bookelaar J, Peters Y, Iyer PG, Siersema PD. Endosheath ultrathin transnasal endoscopy is a cost-effective method for screening for Barrett's esophagus in patients with GERD symptoms. Gastrointest Endosc 2019;89:712-722.e3. [PMID: 30385112 DOI: 10.1016/j.gie.2018.10.024] [Cited by in Crossref: 14] [Cited by in F6Publishing: 15] [Article Influence: 3.5] [Reference Citation Analysis]
|
| 14 |
Wendling MR, Oelschlager BK. Medical and Surgical Therapy for Gastroesophageal Reflux Disease and Barrett Esophagus. Shackelford's Surgery of the Alimentary Tract, 2 Volume Set 2019. [DOI: 10.1016/b978-0-323-40232-3.00033-9] [Reference Citation Analysis]
|
| 15 |
Steinemann DC, Müller PC, Schwarz AC, Zerz A, Linke GR, Müller-Stich BP. Feasibility and effectiveness of laparoscopic transgastric stapler-assisted circumferential esophageal mucosectomy and simultaneous fundoplication in a pig model. Dis Esophagus 2018;31. [PMID: 29788275 DOI: 10.1093/dote/doy030] [Reference Citation Analysis]
|
| 16 |
Singh T, Sanaka MR, Thota PN. Endoscopic therapy for Barrett’s esophagus and early esophageal cancer: Where do we go from here? World J Gastrointest Endosc 2018; 10(9): 165-174 [PMID: 30283599 DOI: 10.4253/wjge.v10.i9.165] [Cited by in CrossRef: 19] [Cited by in F6Publishing: 21] [Article Influence: 3.8] [Reference Citation Analysis]
|
| 17 |
Inadomi JM, Saxena N. Screening and Surveillance for Barrett's Esophagus: Is It Cost-Effective? Dig Dis Sci 2018;63:2094-104. [PMID: 29948571 DOI: 10.1007/s10620-018-5148-7] [Cited by in Crossref: 20] [Cited by in F6Publishing: 15] [Article Influence: 4.0] [Reference Citation Analysis]
|
| 18 |
Chu JN, Choi J, Tramontano A, Morse C, Forcione D, Nishioka NS, Abrams JA, Rubenstein JH, Kong CY, Inadomi JM, Hur C. Surgical vs Endoscopic Management of T1 Esophageal Adenocarcinoma: A Modeling Decision Analysis. Clin Gastroenterol Hepatol 2018;16:392-400.e7. [PMID: 29079222 DOI: 10.1016/j.cgh.2017.10.024] [Cited by in Crossref: 15] [Cited by in F6Publishing: 15] [Article Influence: 3.0] [Reference Citation Analysis]
|
| 19 |
Brimhall B, Wani S. Current Endoscopic Approaches for the Treatment of Barrett Esophagus. J Clin Gastroenterol 2017;51:2-11. [PMID: 27941583 DOI: 10.1097/MCG.0000000000000742] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.8] [Reference Citation Analysis]
|
